Weichang Zhou
Director/Board Member chez WUXI BIOLOGICS (CAYMAN) INC.
Fortune : 451 558 $ au 31/03/2024
Profil
Weichang Zhou is a Non-Executive Director at Wuxi Biologics (Cayman), Inc. since 2012 and at WuXi XDC Cayman, Inc. since 2020.
He previously worked as an Associate Director at Merck & Co., Inc. from 1994 to 2002, as a Senior Director at Genzyme Corp.
from 2008 to 2012, and as a Senior Director at PDL BioPharma, Inc. from 2002 to 2008.
He holds a doctorate degree from the University of Hannover, conferred in 1989, and an undergraduate degree from Jiangxi University of Science & Technology, conferred in 1982.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/03/2024 | 247 139 ( 0,01% ) | 451 558 $ | 31/03/2024 |
Postes actifs de Weichang Zhou
| Sociétés | Poste | Début |
|---|---|---|
| WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | 01/05/2016 |
| WUXI XDC CAYMAN INC. | Director/Board Member | 01/12/2020 |
Anciens postes connus de Weichang Zhou
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Board Member | 01/12/2012 |
| PDL BIOPHARMA, INC. | Director/Board Member | 01/02/2008 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/10/2002 |
Formation de Weichang Zhou
| University of Hannover | Doctorate Degree |
| Jiangxi University of Science & Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
| WUXI XDC CAYMAN INC. | Commercial Services |
| Entreprise privées | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
